Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07 Febbraio 2024 - 1:56PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
|
SCHEDULE 13G/A |
|
Under the Securities Exchange Act of 1934 |
(Amendment No. 1)* |
|
ImmunoGen, Inc. |
(Name of Issuer) |
|
Common Stock, par
value $0.01 per share |
(Title of Class of Securities) |
|
45253H101 |
(CUSIP Number) |
|
December 31, 2023 |
(Date of Event Which Requires Filing of This Statement) |
|
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
|
¨ |
Rule 13d-1(b) |
ý |
Rule 13d-1(c) |
¨ |
Rule 13d-1(d) |
|
(Page 1 of 10 Pages) |
______________________________
*The remainder of this cover page shall be filled
out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. 45253H101 | 13G/A | Page 2 of 10 Pages |
1 |
NAME OF REPORTING PERSON
Adage Capital Partners, L.P. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH: |
5 |
SOLE VOTING POWER
0 |
6 |
SHARED VOTING POWER
971,928 |
7 |
SOLE DISPOSITIVE POWER
0 |
8 |
SHARED DISPOSITIVE POWER
971,928 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
971,928 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.35% |
12 |
TYPE OF REPORTING PERSON
PN |
|
|
|
|
|
CUSIP No. 45253H101 | 13G/A | Page 3 of 10 Pages |
1 |
NAME OF REPORTING PERSON
Adage Capital Partners GP, L.L.C. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH: |
5 |
SOLE VOTING POWER
0 |
6 |
SHARED VOTING POWER
971,928 |
7 |
SOLE DISPOSITIVE POWER
0 |
8 |
SHARED DISPOSITIVE POWER
971,928 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
971,928 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.35% |
12 |
TYPE OF REPORTING PERSON
OO |
|
|
|
|
|
CUSIP No. 45253H101 | 13G/A | Page 4 of 10 Pages |
1 |
NAME OF REPORTING PERSON
Adage Capital Advisors, L.L.C. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH: |
5 |
SOLE VOTING POWER
0 |
6 |
SHARED VOTING POWER
971,928 |
7 |
SOLE DISPOSITIVE POWER
0 |
8 |
SHARED DISPOSITIVE POWER
971,928 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
971,928 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.35% |
12 |
TYPE OF REPORTING PERSON
OO |
|
|
|
|
|
CUSIP No. 45253H101 | 13G/A | Page 5 of 10 Pages |
1 |
NAME OF REPORTING PERSON
Robert Atchinson |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH: |
5 |
SOLE VOTING POWER
0 |
6 |
SHARED VOTING POWER
971,928 |
7 |
SOLE DISPOSITIVE POWER
0 |
8 |
SHARED DISPOSITIVE POWER
971,928 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
971,928 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.35% |
12 |
TYPE OF REPORTING PERSON
IN |
|
|
|
|
|
CUSIP No. 45253H101 | 13G/A | Page 6 of 10 Pages |
1 |
NAME OF REPORTING PERSON
Phillip Gross |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP |
(a) ¨
(b) ¨ |
3 |
SEC USE ONLY |
4 |
CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH: |
5 |
SOLE VOTING POWER
0 |
6 |
SHARED VOTING POWER
971,928 |
7 |
SOLE DISPOSITIVE POWER
0 |
8 |
SHARED DISPOSITIVE POWER
971,928 |
9 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
971,928 |
10 |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |
¨ |
11 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.35% |
12 |
TYPE OF REPORTING PERSON
IN |
|
|
|
|
|
CUSIP No. 45253H101 | 13G/A | Page 7 of 10 Pages |
Item 1(a). |
NAME OF ISSUER |
|
The name of the issuer is ImmunoGen, Inc. (the “Company”). |
Item 1(b). |
ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES |
|
The Company’s principal executive offices are located at 830 Winter Street, Waltham, MA 02451. |
Item 2(a). |
NAME OF PERSON FILING |
|
This statement is filed by: |
|
(i) |
Adage Capital Partners, L.P., a Delaware limited partnership (“ACP”) with respect to the Common Stock and the shares of Common Stock issuable upon exercise of warrants directly owned by it; |
|
|
|
(ii) |
Adage Capital Partners GP, L.L.C., a limited liability company organized under the laws of the State of Delaware (“ACPGP”), as general partner of ACP with respect to the Common Stock and the shares of Common Stock issuable upon exercise of warrants directly owned by ACP; |
|
|
|
(iii) |
Adage Capital Advisors, L.L.C., a limited liability company organized under the laws of the State of Delaware (“ACA”), as managing member of ACPGP, general partner of ACP, with respect to the Common Stock and the shares of Common Stock issuable upon exercise of warrants directly owned by ACP; |
|
|
|
(iv) |
Robert Atchinson (“Mr. Atchinson”), as managing member of ACA, managing member of ACPGP, general partner of ACP with respect to the Common Stock and the shares of Common Stock issuable upon exercise of warrants directly owned by ACP; and |
|
|
|
(v) |
Phillip Gross (“Mr. Gross”), as managing member of ACA, managing member of ACPGP, general partner of ACP with respect to the Common Stock and the shares of Common Stock issuable upon exercise of warrants directly owned by ACP. |
|
The foregoing persons are hereinafter sometimes collectively referred to as the “Reporting Persons.” Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. |
|
|
|
The filing of this statement should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein. |
Item 2(b). |
ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE |
|
The address of the business office of each of the Reporting Persons is 200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116. |
Item 2(c). |
CITIZENSHIP |
|
ACP is a limited partnership organized under the laws of the State of Delaware. ACPGP and ACA are limited liability companies organized under the laws of the State of Delaware. Messrs. Gross and Atchinson are citizens of the United States. |
CUSIP No. 45253H101 | 13G/A | Page 8 of 10 Pages |
Item 2(d). |
TITLE OF CLASS OF SECURITIES |
|
Common stock, par value $0.01 per share (the “Common Stock”). |
Item 2(e). |
CUSIP NUMBER |
|
45253H101 |
Item 3. |
IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: |
|
(a) |
¨ |
Broker or dealer registered under Section 15 of the Act; |
|
(b) |
¨ |
Bank as defined in Section 3(a)(6) of the Act; |
|
(c) |
¨ |
Insurance company as defined in Section 3(a)(19) of the Act; |
|
(d) |
¨ |
Investment company registered under Section 8 of the Investment Company Act of 1940; |
|
(e) |
¨ |
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); |
|
(f) |
¨ |
An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F);
|
|
(g) |
¨ |
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); |
|
(h) |
¨ |
A savings association as defined in Section 3(b) of the Federal Deposit
Insurance Act;
|
|
(i) |
¨ |
A church plan that is excluded from the definition of an investment company
under Section 3(c)(14) of the Investment Company Act;
|
|
(j) |
¨ |
A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); |
|
(k) |
¨ |
Group, in accordance with Rule 13d-1(b)(1)(ii)(K). |
|
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please |
|
specify the type of institution: Not applicable |
|
Item 4. |
OWNERSHIP |
|
|
A. |
Adage Capital Partners, L.P., Adage Capital Partners GP, L.L.C. and Adage Capital Advisors, L.L.C. |
|
|
|
(a) |
Amount beneficially owned: 971,928 shares of Common Stock |
|
|
|
(b) |
Percent of class: 0.35%. The percentage set forth in this Schedule 13G/A is calculated based upon 279,354,016 shares of Common Stock outstanding as of December 29, 2023, as reported in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on January 2, 2024. |
|
|
(c) |
(i) |
Sole power to vote or direct the vote: 0 |
|
|
|
(ii) |
Shared power to vote or direct the vote: 971,928 shares of Common Stock |
|
|
|
(iii) |
Sole power to dispose or direct the disposition: 0 |
|
|
|
(iv) |
Shared power to dispose or direct the disposition of: 971,928 shares of Common Stock |
|
|
|
|
|
|
CUSIP No. 45253H101 | 13G/A | Page 9 of 10 Pages |
ACP has the power to dispose of and the power to vote the Common Stock beneficially owned by it, which power may be exercised by its general partner, ACPGP. ACA, as managing member of ACPGP, directs ACPGP’s operations. Neither ACPGP nor ACA directly own any Common Stock. By reason of the provisions of Rule 13d-3 of the Securities Exchange Act of 1934 (the “Act”), ACPGP and ACA may be deemed to beneficially own the shares owned by ACP. |
|
B. |
Robert Atchinson and Phillip Gross |
|
|
(a) |
Amount beneficially owned: 971,928 shares of Common Stock |
|
|
(b) |
Percent of class: 0.35% |
|
|
(c) |
(i) |
Sole power to vote or direct the vote: 0 |
|
|
|
(ii) |
Shared power to vote or direct the vote: 971,928 shares of Common Stock |
|
|
|
(iii) |
Sole power to dispose or direct the disposition: 0 |
|
|
|
(iv) |
Shared power to dispose or direct the disposition: 971,928 shares of Common Stock |
Messrs. Atchinson and Gross, as managing members of ACA, have shared power to vote the Common Stock beneficially owned by ACP. Neither Mr. Atchinson nor Mr. Gross directly own any Common Stock. By reason of the provisions of Rule 13d-3 of the Act, each may be deemed to beneficially own the shares beneficially owned by ACP. |
Item 5. |
OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS |
|
If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ý |
Item 6. |
OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON |
|
Not applicable. |
Item 7. |
IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON |
|
Not applicable. |
Item 8. |
IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP |
|
Not applicable. |
Item 9. |
NOTICE OF DISSOLUTION OF GROUP |
|
Not applicable. |
Item 10. |
CERTIFICATION |
|
Each of the Reporting Persons hereby makes the following certification: |
|
|
|
By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. |
CUSIP No. 45253H101 | 13G/A | Page 10 of 10 Pages |
SIGNATURES
After reasonable inquiry
and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement
is true, complete and correct.
DATE: February 7, 2024
ADAGE CAPITAL PARTNERS, L.P. |
|
By: Adage Capital Partners GP, L.L.C., |
|
its general partner |
|
|
|
By: Adage Capital Advisors, L.L.C., |
|
its managing member |
|
|
|
/s/ Robert Atchinson |
|
Name: Robert Atchinson |
|
Title: Managing Member |
|
|
|
ADAGE CAPITAL PARTNERS GP, L.L.C. |
|
By: Adage Capital Advisors, L.L.C., |
|
its managing member |
|
|
|
/s/ Robert Atchinson |
|
Name: Robert Atchinson |
|
Title: Managing Member |
|
|
|
ADAGE CAPITAL ADVISORS, L.L.C. |
|
|
|
/s/ Robert Atchinson |
|
Name: Robert Atchinson |
|
Title: Managing Member |
|
|
|
ROBERT ATCHINSON |
|
|
|
/s/ Robert Atchinson |
|
ROBERT ATCHINSON, individually |
|
|
|
PHILLIP GROSS |
|
|
|
/s/ Phillip Gross |
|
PHILLIP GROSS, individually |
|
Grafico Azioni ImmunoGen (NASDAQ:IMGN)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni ImmunoGen (NASDAQ:IMGN)
Storico
Da Nov 2023 a Nov 2024